Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant

Journal of Psychiatric Research

Volumn 68, Issue , 2015, Pages 68-73

  Ballard, Elizabeth D ^a   Luckenbaugh, David A ^a   Richards, Erica M ^a   Walls, Tessa L ^a   Brutsché, Nancy E ^a   Ameli, Rezvan ^a   Niciu, Mark J ^a   Vande Voort, Jennifer L ^a   Zarate, Carlos A ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Assessment; Depression; Ketamine; Psychometrics; Suicidal ideation

Indexed keywords

KETAMINE; LITHIUM; PLACEBO; VALPROIC ACID; ANTIDEPRESSANT AGENT; CLOZAPINE;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; BIPOLAR DEPRESSION; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; EFFECT SIZE; FEMALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUICIDAL IDEATION; SUICIDE ATTEMPT; TREATMENT RESISTANT DEPRESSION; ADOLESCENT; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; STATISTICS; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; CLOZAPINE; CROSS-OVER STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; KETAMINE; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STATISTICS AS TOPIC; SUICIDAL IDEATION; TIME FACTORS; YOUNG ADULT;

EID: 84937880089     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2015.06.003     Document Type: Article

References (27)

1. Beck A.T., Kovacs M., Weissman A. Assessment of suicidal intention: the scale for suicide ideation. JConsult Clin Psychol 1979, 47:343-352.
2. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
3. Brown G.K. Areview of suicide assessment measures for intervention research with adults and older adults 2002, National Institute of Mental Health.
4. Crawford M.J., Thana L., Methuen C., Ghosh P., Stanley S.V., Ross J., et al. Impact of screening for risk of suicide: randomised controlled trial. Br J Psychiatry 2011, 198:379-384.
5. Desseilles M., Perroud N., Guillaume S., Jaussent I., Genty C., Malafosse A., et al. Is it valid to measure suicidal ideation by depression rating scales?. JAffect Disord 2012, 136:398-404.
6. DiazGranados N., Ibrahim L., Brutsche N.E., Ameli R., Henter I.D., Luckenbaugh D.A., et al. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. JClin Psychiatry 2010, 71:1605-1611.
7. Diazgranados N., Ibrahim L., Brutsche N.E., Newberg A., Kronstein P., Khalife S., et al. Arandomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 2010, 67:793-802.
8. First M.B., Spitzer R.L., Gibbon M., Williams J.B. Structured clinical interview for DSM-IV TR Axis I disorders, research version 2001, Patient Edition, New York State Psychiatric Institute, Biometrics Research, New York.
9. Goldston D. Assessment of suicidal behaviors and risk among children and adolescents 2000, Technical report submitted to NIMH under Contract No. 263-MD-909995.
10. Gould M.S., Marrocco F.A., Kleinman M., Thomas J.G., Mostkoff K., Cote J., et al. Evaluating iatrogenic risk of youth suicide screening programs: a randomized controlled trial. JAMA 2005, 293:1635-1643.
11. Hamilton M. Arating scale for depression. JNeurol Neurosurg Psychiatry 1960, 23:56-62.
12. Ibrahim L., Diazgranados N., Franco-Chaves J., Brutsche N., Henter I.D., Kronstein P., et al. Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study. Neuropsychopharmacology 2012, 37:1526-1533.
13. Jobes D.A., Nelson K.N., Peterson E.M., Pentiuc D., Downing V., Francini K., et al. Describing suicidality: an investigation of qualitative SSF responses. Suicide Life Threat Behav 2004, 34:99-112.
14. Klonsky E.D., May A.M. Differentiating suicide attempters from suicide ideators: a critical frontier for suicidology research. Suicide Life Threat Behav 2014, 44:1-5.
15. Larkin G.L., Beautrais A.L. Apreliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department. Int J Neuropsychopharmacol 2011, 14:1127-1131.
16. Lee B.H., Kim Y.K. Potential peripheral biological predictors of suicidal behavior in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:842-847.
17. Luckenbaugh D.A., Ameli R., Brutsche N., Zarate C.A. Rating depression over brief time intervals with the Hamilton depression rating scale: standard vs. abbreviated scales. JPsychiatr Res 2015, 61:40-45.
18. Mathias C.W., Michael Furr R., Sheftall A.H., Hill-Kapturczak N., Crum P., Dougherty D.M. What's the harm in asking about suicidal ideation?. Suicide Life Threat Behav 2012, 42:341-351.
19. Montgomery S.A., Asberg M. Anew depression scale designed to be sensitive to change. Br J Psychiatry 1979, 134:382-389.
20. National Action Alliance for Suicide Prevention: Research Prioritization Task Force Aprioritized research agenda for suicide prevention: an action plan to save lives 2014, National Institute of Mental Health and the Research Prioritization Task Force, Rockville, MD.
21. Niciu M.J., Luckenbaugh D.A., Ionescu D.F., Guevara S., Machado-Vieira R., Richards E.M., et al. Clinical predictors of ketamine response in treatment-resistant major depression. JClin Psychiatry 2014, 75:e417-23.
22. Nock M.K., Park J.M., Finn C.T., Deliberto T.L., Dour H.J., Banaji M.R. Measuring the suicidal mind: implicit cognition predicts suicidal behavior. Psychol Sci 2010, 21:511-517.
23. Posner K., Brown G.K., Stanley B., Brent D.A., Yershova K.V., Oquendo M.A., et al. The Columbia-Suicide severity rating scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry 2011, 168:1266-1277.
24. Price R.B., Iosifescu D.V., Murrough J.W., Chang L.C., Al Jurdi R.K., Iqbal S.Z., et al. Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression. Depress Anxiety 2014, 31:335-343.
25. Weitz E., Hollon S.D., Kerkhof A., Cuijpers P. Do depression treatments reduce suicidal ideation? The effects of CBT, IPT, pharmacotherapy, and placebo on suicidality. JAffect Disord 2014, 167:98-103.
26. Zarate C.A., Brutsche N.E., Ibrahim L., Franco-Chaves J., Diazgranados N., Cravchik A., et al. Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry 2012, 71:939-946.
27. Zarate C.A., Singh J.B., Carlson P.J., Brutsche N.E., Ameli R., Luckenbaugh D.A., et al. Arandomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006, 63:856-864.